Sugentech Inc Asset Resilience Ratio
Sugentech Inc asset resilience ratio. Sugentech Inc (253840) has an Asset Resilience Ratio of 21.51% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 253840 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Sugentech Inc (2017–2025)
Asset resilience ratio of Sugentech Inc from 2017 to 2025. This chart shows how Sugentech Inc's Asset Resilience Ratio has changed over time. Read Sugentech Inc total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Sugentech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 253840 total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩18.78 Billion | 21.51% |
| Total Liquid Assets | ₩18.78 Billion | 21.51% |
Asset Resilience Insights
- Good Liquidity Position: Sugentech Inc maintains a healthy 21.51% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Sugentech Inc Industry Peers by Asset Resilience Ratio
Compare Sugentech Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Applied BioCode
TW:6598 |
Medical Devices | 9.75% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Radiant Innovation
TWO:3373 |
Medical Devices | 0.82% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Sugentech Inc Asset Resilience Ratio by Year (2017–2025)
Sugentech Inc asset resilience ratio by year from 2017 to 2025. The table below shows the annual Asset Resilience Ratio data for Sugentech Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 25.25% | ₩24.80 Billion ≈ $16.81 Million |
₩98.21 Billion ≈ $66.56 Million |
-24.49pp |
| 2024-12-31 | 49.75% | ₩53.55 Billion ≈ $36.29 Million |
₩107.64 Billion ≈ $72.95 Million |
-0.32pp |
| 2023-12-31 | 50.07% | ₩66.68 Billion ≈ $45.19 Million |
₩133.19 Billion ≈ $90.26 Million |
-13.34pp |
| 2022-12-31 | 63.40% | ₩109.87 Billion ≈ $74.46 Million |
₩173.30 Billion ≈ $117.44 Million |
-6.24pp |
| 2021-12-31 | 69.64% | ₩108.34 Billion ≈ $73.42 Million |
₩155.56 Billion ≈ $105.42 Million |
+20.59pp |
| 2020-12-31 | 49.06% | ₩35.54 Billion ≈ $24.09 Million |
₩72.46 Billion ≈ $49.10 Million |
-15.92pp |
| 2019-12-31 | 64.97% | ₩29.51 Billion ≈ $20.00 Million |
₩45.42 Billion ≈ $30.78 Million |
+29.53pp |
| 2018-12-31 | 35.44% | ₩8.64 Billion ≈ $5.85 Million |
₩24.37 Billion ≈ $16.52 Million |
+17.02pp |
| 2017-12-31 | 18.42% | ₩3.37 Billion ≈ $2.28 Million |
₩18.28 Billion ≈ $12.39 Million |
-- |
About Sugentech Inc
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2… Read more